Innovators vs Exploiters: Drug Pricing And The Future Of Pharma
Pharmaceutical pricing got thrown onto the front page again last week, causing the expected anaphylactic reactions among politicians, practitioners, and parents. The root of this crisis: Epipen’s 600% price increase over the past eight years. The biannual upticks underlying that number finally caused a blowback as back-to-school buyers were faced with big out of pocket expenses this year that their insurers passed onto them. Read more here.
Home / Featured (sidebar) / Innovators vs Exploiters: Drug Pricing And The Future Of Pharma